Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001209191-16-119316
Filing Date
2016-05-11
Accepted
2016-05-11 18:59:42
Documents
1
Period of Report
2016-05-11

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 20003
  Complete submission text file 0001209191-16-119316.txt   22707
Mailing Address 130 BROOKLINE STREET SUITE 201 CAMBRIDGE MA 02139
Business Address 130 BROOKLINE STREET SUITE 201 CAMBRIDGE MA 02139 857-285-6200
Intellia Therapeutics, Inc. (Issuer) CIK: 0001652130 (see all company filings)

EIN.: 364785571 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2835 In Vitro & In Vivo Diagnostic Substances

Mailing Address 25 FIRST ST STE 303 CAMBRIDGE MA 02141
Business Address 25 FIRST ST STE 303 CAMBRIDGE MA 02141 6175882695
Atlas Venture Associates IX, LLC (Reporting) CIK: 0001671207 (see all company filings)

State of Incorp.: DE | Fiscal Year End: 1012
Type: 4 | Act: 34 | File No.: 001-37766 | Film No.: 161641250

Mailing Address 25 FIRST ST STE 303 CAMBRIDGE MA 02141
Business Address 25 FIRST ST STE 303 CAMBRIDGE MA 02141 6175882695
Atlas Venture Associates IX, L.P. (Reporting) CIK: 0001671208 (see all company filings)

State of Incorp.: DE | Fiscal Year End: 1012
Type: 4 | Act: 34 | File No.: 001-37766 | Film No.: 161641251

Mailing Address 25 FIRST ST STE 303 CAMBRIDGE MA 02141
Business Address 25 FIRST ST STE 303 CAMBRIDGE MA 02141 6175882695
Atlas Venture Fund IX, L.P. (Reporting) CIK: 0001671219 (see all company filings)

State of Incorp.: DE | Fiscal Year End: 1012
Type: 4 | Act: 34 | File No.: 001-37766 | Film No.: 161641252